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Abstract: In the present review we summarize the relationship between the amino acid, tryptophan, the neurotransmitter, 
serotonin, and the indole, melatonin, with the rhythms of sleep/wake and the immune response along with the possible 
connections between the alterations in these rhythms due to aging and the so-called “serotonin and melatonin deﬁ  ciency 
state.” The decrease associated with aging of the brain and circulating levels of serotonin and melatonin seemingly contributes 
to the alterations of both the sleep/wake cycle and the immune response that typically accompany old age. The supplemental 
administration of tryptophan, e.g. the inclusion of tryptophan-enriched food in the diet, might help to remediate these age-
related alterations due to its capacity of raise the serotonin and melatonin levels in the brain and blood. Herein, we also 
summarize a set of studies related to the potential role that tryptophan, and its derived product melatonin, may play in the 
restoration of the aged circadian rhythms of sleep/wake and immune response, taking the ringdove (Streptopelia risoria) as 
a suitable model.
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Introduction
Tryptophan is a polar, hydrophobic amino acid indispensable for protein synthesis. It is classiﬁ  ed as an 
“essential” amino acid, i.e. it cannot be synthesized by the human organism and must therefore be 
ingested in the diet. Once tryptophan is consumed, it is readily absorbed into the capillaries in the 
intestinal wall. A small amount of the amino acid remains free while the majority of it (roughly 80%–90%) 
is transported bound to albumin through the blood and into the brain. This transport may be altered by 
the competition exerted by other free, neutral amino acids of high molecular weight, branched-chain 
amino acids, including valine, leucine and isoleucine, as well as phenylalanine and tyrosine, which bind 
to the same transporters.
1,2
The metabolism of tryptophan is complex. It is involved in a variety of metabolic pathways and 
requires a suitable quantity of biopterin, magnesium or vitamin B6, which is involved in the conversion 
of the amino acid into serotonin and in the metabolism of other by-products, such as kynurenine. The 
main precursor of tryptophan is the anthralinic acid or anthranilate, a compound that after a series of 
chemical reactions is transformed into indole-3-glycerolphosphate. The enzyme tryptophan synthase 
converts this latter compound into glyceraldehyde 3-phosphate in a two-step reaction with the interme-
diary indole bound to the active site of the enzyme and with the intervention of serine (Fig. 1). The 
contribution of tryptophan to energetic metabolism is double since on one hand it is ketogenic, i.e. it 
forms acetyl coenzyme A, and on the other it is glucogenic, as it produces alanine.
3
Tryptophan is transported to the liver where it is metabolized. Thereafter, in consecutive reactions 
it is transformed into nicotinic acid and other subproducts that either are stored or serve as a basis for 
important substances including quinolinate, picolinate or glutarate.
4
The amino acid tryptophan is the precursor of several important products including serotonin or 
melatonin (Fig. 2). These molecules are biogenic amines of low molecular weight that belong to the 24
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indole group. It has been observed that the synthesis 
of melatonin in the pineal gland diminishes with 
aging.
5–7 This is believed to be due to degenerative 
changes in the neural structures (postganglionic 
neurons) innervating the pineal gland and central 
nervous system, rather than to the degeneration of 
the pineal tissue per se,
8 as well as to a reduction 
in the quantity of the necessary precursor, 
serotonin.
7,9,10 However, the number or sensitivity 
of melatonin receptors throughout the organism 
may decline with age as a result of the usual degen-
erative processes.
11 The result is the development 
of the so-called “serotonin and melatonin deﬁ  -
ciency state.”
12–14 This age-related state seemingly 
contributes to the alterations of both the sleep-wake 
cycle and the immune responsivity that character-
izes aging. Thus, the consumption of tryptophan 
as a pharmacological agent or as part of a diet rich 
in this amino acid may attenuate age-related 
changes in circadian organization, the immune 
system, sleep, and other disorders, due to its abil-
ity to elevate circulating levels of serotonin and 
melatonin.
15–18
This review is constructed to provide a concise 
view of the effects of tryptophan, serotonin and 
melatonin on the sleep-wake cycle and the immune 
system responses, to identify possible links between 
the impairment of these rhythms and the reduction 
in serotonin and melatonin levels in the aging 
organism, and to illustrate the potential restorative 
role that tryptophan may play against the age-related 
afore-mentioned circadian alterations. Finally, we 
present the ring dove (Streptopelia risoria) as a 
suitable model for the study of the aged sleep-wake 
or activity-rest rhythms and immunosenescence 
and summarize the results obtained in this animal 
species in the circadian rhythm research ﬁ  eld over 
the last decade.
Tryptophan, Serotonin, Melatonin, 
and the Sleep-wake Cycle
The initiation of investigations related to the hyp-
notic effects that tryptophan exerts on the human 
sleep dates back to the 70s and 80s,
19,20 when it 
was observed that this amino acid augmented the 
propensity to sleep. During this interval tryptophan 
was used as a successful therapeutic agent to com-
bat chronic insomnia.
21 More recently, the con-
solidation properties of tryptophan for the 
sleep-wake rhythm of newborns have been tested. 
It has been shown that being fed with nutritionally 
dissociated milk formulas, i.e. a diurnal formula 
with low content of tryptophan and carbohydrates 
and a high amount of protein, supplemented 
with the nucleotides cytidine 5-monophosphate, 
guanosine 5-monophosphate and inosine 
5-monophosphate, and a nocturnal formula that 
contains high levels of tryptophan and carbohy-
drates, a low level of protein, with the nucleo-
tides adenosine 5-monophosphate and uridine 
5-monophosphate, improved the total hours of 
sleep, the efﬁ  ciency of sleep, the minutes of noctur-
nal immobility, and reduced both the number of 
nocturnal awakenings and the sleep latency of 
newborns.
22,23 This is of special importance at a 
stage of life where an appropriate rest period is 
directly related to an optimal development of both 
the nervous and immune systems.
The ﬁ  rst studies showing a relationship between 
serotonin and sleep appeared in the middle of the 
50s. It was observed that reserpine, an antipsychotic, 
antihypertensive indole alkaloid dimin  ished the 
concentration of serotonin in the brain and induced 
a sedative state analogous to sleep.
24 It was also 
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Figure 1. Scheme of the conversion of anthranilic acid to tryptophan. 
PRPP, phosphoribosylpyrophosphate; PP3, pyrophosphate; PRA, 
N-(5’Phosphoribosyl)-anthranilate; CDRP, 1-(o-Carboxyphenylamino)-
1-deoxyribulose-5-phosphate; InGP, indole-3-glycerolphosphate.25
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reported that the parenteral injection of L-5-
hydroxytryptamine caused cortical synchronization 
and that inhibitors of the enzyme monoamine oxi-
dase selectively suppressed paradoxical sleep or 
REM for long periods of time that could persist for 
days or even weeks.
25 Serotonin subsequently 
appeared as a key factor in understanding some of 
the mechanisms involved in the sleep-wake cycle. 
In fact, subsequent investigations documented that 
the destruction of the raphe nuclei, an area with an 
abundance of serotonin-containing neurons, by 
means of coagulation, produced insomnia for 
lengthy periods of time (10–15 days). Thus, a 
relationship among insomnia intensity, the magni-
tude of the injury in the raphe nuclei and the 
amount of brain serotonin that remained in the 
telencephalon after the degeneration of the sero-
toninergic terminals was established. Particularly, 
a correlation between the destruction of the rostral 
raphe and the slow-wake sleep and the telence-
phalic serotonin, which decreased, and between 
paradoxical sleep and damage to the nucleus raphe 
magnus was identiﬁ  ed.
26,27 It was additionally 
pointed out that p-chlorophenylalanine inhibited 
the enzyme tryptophan hydroxylase, which in turn 
impaired the biosynthesis of serotonin and second-
arily led to states of total insomnia.
28
These experiments led to the elaboration of the 
so-called “monoaminergic theory of sleep.” This 
established that serotonin, or somnotonin as it was 
named by Koella,
29 was the neurotransmitter or 
“neurohormone” of sleep, since it produced sleep 
by the inhibition of the reticular formation and 
locus ceruleus, the putative centers of wakefulness. 
Conversely, catecholamines were found to be 
responsible for awakening. The demonstration, 
however, that the electric activity of serotoninergic 
neurons as well as the release of serotonin increased 
during wakefulness and decreased with sleep was 
seemingly in clear contradiction with the afore-
mentioned theory. In the late 80s, however, a 
relationship between the sleep/wake cycle and 
serotonin was again considered. More recent 
experiments suggest that during wakefulness, 
serotonin is responsible for initiating a cascade of 
post-synaptic genomic processes in hypnogenic 
neurons located in the pre-optic area.
30 Through 
these processes, the release of the neurotransmitter 
during wakefulness leads to a homeostatic regula-
tion of slow wave sleep,
30 also acting as a positive 
modulator of melatonin synthesis.
31
Among the diverse physiological functions in 
which melatonin has been involved, its role as 
regulator of the sleep/wake rhythms has attracted 
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Figure 2. Pathways of indole metabolism in photosensitive pineal cells. Enzymes: AADA, aromatic L-amino acid decarboxylase; AA-NAT, 
aralkylamine N-acetyltransferase; DeAc, deacetylase; HIOMT, hydroxyindole-O-methyltransferase; MAO, monoamine oxidase; TPH, tryptophan 
hydroxylase. Indoles: N-acetyl-serotonin; 5-HIAA, 5-Hydroxyindoleacetic acid; 5-HTL, 5-hydroxytryptophol; 5-MIAA, 5-methoxyindole-3-acetic. 
Chemical structure of melatonin is shown at the bottom of the ﬁ  gure (taken from Paredes, 2007,
178 modiﬁ  ed).26
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the attention of a number of sleep researchers in 
the last decade. The discovery that melatonin was 
mainly secreted at night and the tight relationship 
between the nocturnal increase of endogenous 
melatonin and the existing co-ordination of sleep 
as well as the pro-somnogenic effects that the 
pineal indole seemingly possessed, led many inves-
tigators to suggest that melatonin was likely impli-
cated in the physiological regulation of sleep. With 
regard to this presumption, it was observed that 
the suppression of the production of melatonin 
using β-blockers correlated with insomnia,
32–34 
while the increase of the plasma levels of melato-
nin by reducing the activity of the enzymes that 
metabolize the indole in the liver resulted in an 
augmentation of the somnolence state.
35
It was reported that during the wake period 
immediately prior to sleep, known as the wake-
maintenance zone or “forbidden zone” for sleep,
36 
the propensity for sleep is reduced to a minimum 
and, at the same time, the activity of the neurons 
of the central nervous system is elevated.
37,38 Thus, 
the transition from the wake stage to a period of 
high propensity for sleep coincides with the noc-
turnal elevation of the endogenous rhythm of 
melatonin.
39 This increase seems to be temporally 
related to the opening of the so-called sleep 
gate.
40,41
Taking into account the relationship between 
the endogenous secretion of melatonin and the 
opening of the entry into nocturnal sleep, it has 
been proposed that the role of the pineal indole 
does not involve an active induction of sleep, rather 
it consists of the inhibition of the mechanisms 
that generate the circadian period of wakefulness,
42 
presumably through the MT1 melatonin receptor
43,44 
and GABAergic activation
45,46 at the central 
nervous system level.
Regarding the effects of the exogenous admin-
istration of melatonin on sleep and the circadian 
clock, there are a number of studies reporting that 
diurnal treatment with the indole produces drowsi-
ness,
47–51 as well as raising the circulating levels of 
melatonin to values normally observed at night.
52
For these reasons, melatonin, through its actions 
in the central nervous system, is seemingly a cru-
cial substance for the co-ordination of the circadian 
mechanism of sleep. However, the recent discovery 
of melatonin receptors in other brain areas such 
as the hippocampus
53 makes necessary further 
investigation to elucidate the exact role of melato-
nin on sleep in the different brain structures. 
Moreover, considering the rather high levels of 
melatonin in certain plant foodstuffs (Table 1),
54 the 
consumption of melatonin through the diet may have 
signiﬁ  cant beneﬁ  ts to human and animal health.
Tryptophan, Serotonin, Melatonin, 
and the Immune System
The concentration of the amino acid tryptophan is 
lower in psychologically depressed patients with 
respect to control individuals.
55 This consequently 
produces a decrease in the levels of serotonin, a 
neurotransmitter that has frequently been impli-
cated in depressive syndromes.
56 Moreover, it has 
been observed that when depressive disorders 
appear, they are accompanied by an inﬂ  ammatory 
response involving the immune system, which is 
inversely proportional to the concentration of 
tryptophan in plasma.
57 This is also negatively 
correlated to the number of leukocytes and other 
components of the immune system including inter-
leukin 6 (IL-6) and IL-8.
58 It has been reported that 
individuals with sleep disturbances experience the 
same symptoms as patients suffering from depres-
sion, i.e. a diminution of the tryptophan levels in 
plasma and an augmentation of both IL-6 and IL-8, 
compared to healthy individuals.
56,57 They also 
experience a decrease in the levels of IL-2.
59 On 
the other hand, when interruption of sleep for 
5 hours during the nocturnal period occurs, the 
levels of IL-1 and IL-2 are elevated. When som-
nolence is produced in excess, IL-6 and tumor 
necrosis factor α (TNF-α) are elevated,
60 with a 
subsequent rise in the number of monocytes and 
neutorphils.
61
Regarding the effect that the amino acid exerts 
on the phagocytic function, recent studies suggest 
an enhancement of phagocytosis after the oral 
administration of tryptophan. Particularly, it has 
been observed that administering the amino acid 
to rats causes incremental changes in circulating 
levels of melatonin as well as stimulating the 
antigenic capacity of ingestion of peritoneal mac-
rophages obtained during the nocturnal period.
15,62 
An elevation of the phagocytic capacity at night 
has also been observed in otherwise untreated rats 
and mice.
63–66 This suggests that the activation of 
the innate immune response after tryptophan con-
sumption may be due to its conversion into the 
pineal indole. In fact, it has been shown that mac-
rophages obtained from the peritoneal cavity of 
normal rats when incubated with tryptophan show 27
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Table 1. Levels of melatonin in representative common vegetables and fruits measured using different methods 
by Dubbels et al.
175 (1), Hattori et al.
176 (2), and Badria
177 (3).
Common name Scientiﬁ  c name Melatonin (1)
a Melatonin (2)
b Melatonin (3)
c
Apple Malus domestica – 47.6 ± 3.1 16.1
Asparagus Asparagus ofﬁ  cinalis – 9.5 ± 3.2 –
Banana Musa ensete – – 65.5
Banana Musa sapientum 46.6 – –
Beetroot Beta vulgaris 0.2 – –
Cabbage Brassica oleracea var. capitata – 107.4 ± 7.3 30.9
Carrot Daucus carota – 55.3 ± 11.9 49.4
Corn Zea mays – 1366.1 ± 465.1 187.8
Cucumber Cucumis sativus 8.6 24.6 ± 3.5 59.2
Garlic Allium sativum – – 58.7
Ginger Zingiber ofﬁ  cinale – 583.7 ± 50.3 142.3
Kiwi fruit Actinidia chinensis – 24.4 ± 1.7 –
Onion Allium cepa – 31.5 ± 4.8 29.9
Pineapple Ananas comosus – 36.2 ± 8.4 27.8
Pomegranate Punica granatum – – 16.8
Radish Raphanus sativus – – 75.8
Rice Oryza sativa – 1006.0 ± 58.5 149.8
Strawberry Fragaria magna – 12.4 ± 3.1 13.6
Tomato Lycopersicon esculentum 50.6 32.2 ± 2.4 –
Tomato Lycopersicon pimpinellifolium 11.2 – 30.2
ang/100 g edible plant material (without peel). Levels measured by RIA and HPLC-MS. 
bpg/g tissue. Levels quantiﬁ  ed by RIA. 
cng/100 g. 
Levels measured by GC/MS analysis.
an increase in arylalkylamine N-acetyltransferase 
activity which corresponds to a rise in melatonin 
production.
67 Nevertheless, tryptophan is also the 
precursor of serotonin, a compound that may also 
play a role in the function of the innate immune 
system. Owing to the fact that receptors for 
serotonin exist in leukocytes and a transporter for 
this amine has been found in macrophages, mono-
nuclear leukocytes, and B cells, this neurotransmit-
ter may be a critical element for the connection 
between the nervous and immune systems.
68,69 
Some studies have shown that serotonin may also 
possess an antioxidative role.
70–72 Serotonin has 
also been reported to inhibit leukocyte phagocy-
tosis,
73,74 especially when the concentrations of 
neurotransmitter used are in the pharmacological 
range.
71 Since circadian variations of serotonin in 
plasma and different brain regions have been 
observed,
75 this may somehow influence the 
circadian daily variations of the immune system.
A substantial body of research has defined 
melatonin as a remarkable molecule with pleiotropic 
effects both of an endocrine and a non-endocrine 
nature on the immune system.
76–78 The abolition 
of the daily rhythm of melatonin via either surgical 
or functional pinealectomy has been shown to 
directly correlate to weight loss of the thymus as 
well as to the abnormal involution of this immune 
organ; this is also accompanied by a depletion of 
lymphoblasts and an almost total absence of lym-
phocytes.
79 A reduction in the size of lymph nodes 
associated with follicular loss in the outer cortex
80 
together with an alteration of the activities of thy-
mic polyamine biosynthetic amines have also been 
noted.
81–83 Other immune organs such as the spleen 
or the bursa of Fabricius in birds are impaired 
following pinealectomy. In this respect, Brainard 
et al.
79showed a lack of evident germinal centers 
and an apparent inactivity of the red pulp in the 
Syrian hamster spleen, while Jankovic et al.
84 28
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found a delayed development not only in the bursa 
but also in the thymus and spleen of pinealecto-
mized chicks. The absence of the pineal gland has 
also been reported to signiﬁ  cantly reduce IL-2 
production and NK activity
85,86 and decrease the 
cellular and humoral immune response of both 
mammals and birds.
87–90 When melatonin is admin-
istered to pinealectomized animals, the effects on 
immune system are typically reversed.
In vivo models have shown melatonin to be 
considered as a positive regulator of immune 
responses. The administration of melatonin results 
in the enhancement of antigen presentation by 
splenic macrophages in major histocompatibility 
complex II, IL-1 and TNF-α production,
91 the 
increase in the generation of thymosin α1 through 
a rise in prothymosin α gene expression 
92 as well 
as the production of IL-10.
93 In mice, treatment 
with melatonin also upregulates macrophage-
colony stimulating factor, TNF-α, transforming 
growth factor β and stem cell factor gene expression 
in peritoneal macrophages and the levels of IL-1β, 
interferon γ, macrophage-colony stimulating factor, 
TNF-α and stem cell factor in splenocytes.
94
The pineal indole also possesses potential 
positive effects on several immune system pathol-
ogies including acute and chronic inﬂ  ammation
95,96 
and syndromes provoked by certain viruses such 
as the encephalomyocarditis virus,
97 lethal Semliki 
Forest virus and the attenuated non-invasive West 
Nile virus
98 as well as the Venezuelan equine 
encephalomyelitis virus.
99–101
The Serotonin and Melatonin
Deﬁ  ciency State Due to Ageing: 
Effects and Consequences
on the Sleep/wake Cycle
and the Immune System
Aging is associated with a reduction in the size of 
the brain. These changes are generally attributed 
to a loss of neurons in speciﬁ  c layers and regions 
of the brain, although there exists considerable 
interindividual variation.
102 The loss of neurons 
has been shown to occur in the locus ceruleus, the 
main source of catecholaminergic neurons, and in 
the substantia nigra, where dopaminergic neurons 
are most abundant. This may contribute to age-
related changes in homeostasis, sleep alterations, 
stability, movement, and cognitive function.
103 
Alterations tend to affect the myelinated axons (the 
white matter) at a much greater degree when 
compared to the neuron cell bodies in the grey 
matter.
104 Aging has also been proposed to modify 
the permeability of the blood-brain barrier, which 
may have consequences in terms of porosity of this 
structure to different drugs or molecules and to 
cause a decline in the brain metabolism and blood 
ﬂ  ow.
105
Neurotransmitter functions of serotonin are 
widely distributed in the central nervous system 
and are related to the regulation of a variety of 
behaviors. Serotonin is seemingly involved in the 
regulation of humor, anxiety, sleep, appetite, 
sexual function, brain blood ﬂ  ow and many other 
functions. The serotoninergic neurons are located 
in the raphe nuclei of the brain stem and their axons 
project to all brain areas, including the cerebral 
cortex, thalamus, the limbic system and the hypo-
thalamus. In regard to this, any change in the 
number of serotonin receptors or in the endogenous 
levels of the neurotransmitter due to aging may 
have consequences on behaviour or cognitive func-
tion. Diverse studies have shown that alterations 
in serotinergic neurotransmission cause age-related 
alterations. Particularly, a reduction in the density 
of the serotonin type 2 receptor (5HT2A) has been 
described.
106
The injection of altanserin, a high afﬁ  nity ligand 
to 5HT2A receptor union sites, to young and old 
subjects showed that the speciﬁ  c union for this 
receptor was signiﬁ  cantly reduced in old individu-
als compared to the young, as well as the number 
of receptors, whose loss was marked in certain 
brain regions.
106 Since many antidepressant drugs 
typically relieve the symptoms of depression by 
blocking serotonin reuptake in order to facilitate 
an increase in serotonin activity, it is speculated 
that the high incidence of depression in the elderly 
may be attributed to the reduction in serotonin 
receptors. Moreover, it has been reported that 
serotonin receptors and transporters are less sensi-
tive to hormone regulation, which responds to the 
deﬁ  ciency associated to aging of the regulation of 
the hippocampal serotoningeric system exerted by 
corticosterone.
107 This suggests that the age-related 
changes in the neurochemistry of serotonin may 
be a cause of the increased rates of depression and 
hypercortisolemia observed in the aged popula-
tions. In parallel, serotonin is known to increase 
the quality of slow wave sleep,
30 as well as being 
a waking neurotransmitter.
108 In addition, the close 
relationship between serotonergic activity and the 
adjustments of circadian phase has suggested that 29
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serotonin also plays a role in the endogenous 
regulation of the circadian clock.
109 These ﬁ  ndings 
point to the participation of serotonin neurotrans-
mission in the behavioral alterations commonly 
observed in aged individuals and may have poten-
tial therapeutic implications.
Blood melatonin levels show a clear circadian 
rhythm, with low levels during the day and high 
values at night, with these values being 10/15-fold 
greater that those measured in the diurnal 
period.
110,111 In humans, the indole has been shown 
to gradually decrease during the increased life 
span, with the day/night rhythm being practically 
absent in individuals over 65-yr old (Fig. 3).
112 
This observation has also been reported when 
melatonin levels in young and old rats, gerbils, 
hamsters or ringdoves are compared.
113,114 It is 
believed that the amplitude of the nocturnal mela-
tonin rhythm is genetically determined as it shows 
important interindividual differences,
115 even 
though in a given individual it exhibits a high 
degree of ﬁ  delity over time.
116 Hence, some sub-
jects produce signiﬁ  cantly less melatonin in their 
life than others, which may be of importance for 
aging.
13
Aging is a crucial factor in terms of sleep char-
acteristics. The structure, depth, and continuity of 
sleep tend to change over the life span.
117 Some 
reports have shown that more than a third of the 
elderly experience recurrent difﬁ  culty to maintain 
sleep
118 due to impairment in both the quality and 
the quantity of sleep.
119 Sleep onset latency usually 
increases together with the number and duration of 
awakenings, while sleep stability declines, and sleep 
consolidation is altered.
117 It is therefore not surpris-
ing that the information provided by epidemiologic 
studies reveals that up to 40% of individuals over 
65-yr old complain about sleep problems and 
12%–25% suffer from persistent insomnia.
120 The 
number of elderly people that have been prescribed 
sleep drugs or that use aids to facilitate nocturnal 
rest is estimated to be around 14%.
121
Aging also causes alterations in the amplitude 
of the sleep/wake circadian rhythm.
122 The tempo-
ral organization of sleep is impaired and the regu-
latory mechanisms of the sleep processes are 
attenuated.
123 Several reasons suggested for these 
age-related changes are a reduction in the number 
of pinealocytes, changes in retina and in the supra-
chiasmatic nuclei or alterations in melatonin secre-
tion.
124
The effectiveness of the immune system 
decreases during aging. The lymphoid tissues of 
the spleen, bone marrow and thymus are progres-
sively lost; this increases the incidence of infec-
tions, autoimmune diseases and cancer.
125 With 
advancing age, the number and proliferative 
capacity in response to mitogen-stimulation of the 
diverse subpopulations of T-lymphocytes is 
reduced
126,127 while apoptosis is elevated.
128 More-
over, the synthesis and secretion of immunoglobu-
lins is delayed, presumably due to a lack of 
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Figure 3. Diagrammatic representation of daily proﬁ  les of serum melatonin levels throughout lifespan (taken from Karasek and Reiter,
13 
modiﬁ  ed).30
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appropriate levels of cytokines;
129 this decreases 
the competence of antibodies in immunization 
against infectious agents.
130 Antigen-presenting 
cells or accessory cells and phagocytes experience 
an age-related rise in the oxidative state,
131 result-
ing in a reduced capability to adapt to environmen-
tal stress and in a reduction of the phagocytic 
parameters.
114
It is known that the pineal gland inﬂ  uences the 
function of the neuroendocrine system and the 
efﬁ  cacy of the immune system to recognize and 
react to any endogenous or exogenous factor.
132 For 
this reason, it has been suggested that aging is a 
result of the deterioration of this key factor of the 
pineal gland due to a deﬁ  cient melatonin secretion 
and a decline in the melatonin/serotonin ratio. This 
may impair several aspects of an individual’s neu-
rophysiology.
48 It has been observed that early 
extirpation of the pineal gland produces substantial 
accumulations of lipid peroxidation products, 
oxidized DNA, reduced ﬂ  uidity of cell membranes 
and elevated protein damage in many organs.
133 
These changes are a consequence of the loss of the 
endogenous melatonin rhythm. Impairment in 
melatonin synthesis is thought to likely play a role 
in the aging process since this indole participates 
in vital defence mechanisms including free radical 
scavenging and indirect antioxidative actions.
134,135 
Thus, melatonin is estimated to be responsible for 
the scavenging of ten or more reactive damaging 
agents.
136 Furthermore, its initial, secondary, 
tertiary and quaternary derivatives are all potent 
scavengers that, together with melatonin, form a 
remarkable cascade of reactions referred to as 
melatonin’s antioxidative cascade.
136,137 The 
detoxiﬁ  cation of radical and radical products by 
melatonin and its derivatives are receptor-
independent actions and only require that the scav-
enger be at the site where the radical product is 
generated.
138 This is essential since highly reactive 
agents mediate damage in the immediate vicinity 
of where they are produced, i.e. the damage is site 
speciﬁ  c.
138 Melatonin also has receptor-mediated 
actions which adds to the capability of this molecule 
in eradicating radicals and reducing oxidative 
stress.
139,140 Thus, melatonin stimulates a number 
of antioxidative enzymes which metabolize reactive 
products to innocuous agents. The enzymes whose 
activities have been shown to be promoted by 
melatonin include both Cu/Zn and Mn superoxide 
dismutases, glutathione peroxidases and glutathi-
one reductase.
139,141,142 The effects of melatonin on 
the activities of the antioxidative enzymes are likely 
receptor-mediated and involve receptors on the 
plasma membrane and also presumably receptors/
binding sites in the nucleus.
140
The efﬁ  ciency of sleep is also reduced as a result 
of low circulating levels of the pineal indole. These 
phenomena typically accompany advancing age. 
Melatonin may thus protect against the oxidation 
of essential molecules,
143,144 which appear 
in signiﬁ  cant numbers in aged organisms,
145 and 
resist neurodegenerative disorders associated 
with the impairment produced in particular brain 
areas by free radicals.
146 In fact, melatonin may 
possess benefits in Parkinson and Alzheimer 
diseases.
147,148
Pinealectomy is believed to accelerate the aging 
process, causing high blood pressure, elevated 
alkaline phosphatase activity, modiﬁ  cation in the 
synthesis of prostaglandins, and induction of  REM. 
These alterations are seemingly counteracted by 
the administration of melatonin.
149 Many studies 
support the idea that melatonin may be considered 
as an anti-aging and rejuvenating product. The 
evidence accumulated to date supports the hypoth-
esis that the supplemental treatment with melatonin 
may be of beneﬁ  t during aging.
150,151
The Potential Restorative Role
of Tryptophan of the Impaired
in the Sleep/wake Cycle
and Immune System that
Accompany Aging: Streptopelia
Risoria as a model
The ringdove (Sterptopelia risoria) is a species 
characterized by being diurnal and monophasic 
with sleep-wake cycles similar to those of human 
beings and, therefore, it represents a good model 
to investigate impairments in the circadian system 
due to age, including immune alterations.
The ﬁ  rst study performed in the ringdove that 
showed a relationship between the pineal gland, 
melatonin and the immune system was that of 
Rodríguez and Lea.
87 Pinealectomy produced a 
signiﬁ  cant increase in the number of total white 
blood cells and total protein concentration in plasma 
in addition to altering different stages of the phago-
cytic process. Also, during an immunization study, 
a reduction in the percentage of leukocytes and 
lymphocytes and an increase in the percentage of 
heterophils accompanied by a rise in the concentra-
tion of serum corticosterone were observed 3 hr 31
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following treatment. For the immunological 
parameters, adherence capacity and latex bead 
ingestion were increased 3 hr after normal sleep 
serum injection and the nitroblue tetrazolium reduc-
tion test 3 and 24 hr after normal sleep serum treat-
ment. In addition, the administration of normal sleep 
serum produced a signiﬁ  cant increase in serum 
T3 and T4 concentrations 4 days following injec-
tion. These results indicate that the loss of melato-
nin due to pinealectomy has a marked effect on both 
the number and function of immune cells.
In reference to in vivo experiments with mela-
tonin, a correlation between the circadian rhythm 
of the indole, phagocytosis, and superoxide anion 
levels has been reported.
152 Thus, the elevated 
melatonin serum levels during the dark period 
coincide with an enhanced phagocytosis of inert 
particles and lower superoxide anion levels derived 
from the immune system. These effects where 
reinforced when the animals received melatonin 
orally, which also elevated circulating levels of the 
indole.
153,154 Similar results were observed when 
the phagocytosed particle was a living organism 
(Candida albicans) with the effect being dose-
dependent.
153,155 In vitro experiments have reported 
similar results, with the chemoattractant ability for 
heterophils being signiﬁ  cantly enhanced by the 
pineal indole
156 as well as an augmentation of the 
phagocytic function and a decline in the free radical 
production.
65 Melatonin also decreased the super-
oxide dismutase activity (an indicator of the meta-
bolic burst) in heterophils after the ingestion of 
latex beads.
157
The concentration of malonaldehyde in cells is 
an index of induced oxidative damage to membrane 
lipids. The co-incubation of a heterophil suspen-
sion with or without inert particles (latex beads), 
as material to be phagocytosed, in combination 
with melatonin has been shown to clearly reduce 
the production of malonaldehyde. The enhance-
ment of malonaldehyde levels produced by latex 
beads was also annulled in the samples incubated 
with melatonin.
158
In stressful situations, an alteration in the 
endogenous circadian rhythm of melatonin in the 
ringdove has been described.
159 This has also been 
reported in mammals, where a decreased MESOR 
and amplitude of the melatonin rhythm, and a 
signiﬁ  cantly elevated MESOR of the corticoste-
rone rhythm have been observed.
66,160
Streptopelia risoria also experiences a “sero-
tonin and melatonin deficiency state” during 
aging;
7,10 this is associated with increased nocturnal 
activity and depressed immune function.
7,154,161,162 
Under these conditions, orally administered mela-
tonin has been reported to improve nocturnal rest 
not only in old ringdoves, but also in young 
birds.
161,162 This is likely to be a result of a decrease 
in the core temperature and an increase in the 
peripheral temperature observed after the oral 
administration of the indole in this species.
162 Thus, 
melatonin may be used to palliate the reduction in 
the thermoregulatory responses and the capacity 
for thermal comfort reported in the elderly.
163 This 
is of importance since sleep disorders are believed 
to be caused, at least partly, by changes in the cir-
cadian rhythms of temperature and melatonin.
164
The oral administration of the indole restores 
some of the changes that aging produces in the 
innate immune response, with an enhancement in 
the phagocytic processes and a decrease in the 
production of free radicals, reﬂ  ecting the scavenging 
properties of melatonin; this is most probably due 
to the restoration of the nocturnal rise of circulating 
melatonin due to its administration.
153,154,161,165 
This hypothesis is corroborated by previous ﬁ  nd-
ings showing that the incubation of ringdove het-
erophils obtained from old animals with the 
physiological concentrations of serum melatonin 
typical of young and mature birds induced a dose-
dependent rise in both the phagocytic index and 
the candidicide capacity, together with a decline 
in superoxide anion levels.
166 Furthermore, the 
incubation of old heterophils with the physiologi-
cal concentrations of melatonin characteristic of 
young animals (50 and 300 pg/ml, diurnal and 
nocturnal, respectively) counteracted the enhance-
ment of malonaldehyde levels caused by latex 
beads, with the effect being greater at the longer 
incubation time tested.
167
Once the potential role of the pineal indole to 
reverse the age-related alteration in the activity/rest 
rhythms and immune impairment in the ringdove 
was documented, the next step was to test whether 
tryptophan, the precursor of melatonin and also of 
the neurotransmitter serotonin would have similar 
effects. Tryptophan administered in the diet is known 
to increase the availability of serotonin in the brain, 
improve the EEG delta potential, and elevate the 
amount of NREM.
168 It has also been observed in 
mammals that orally ingested tryptophan increases 
brain levels of serotonin during the day and the 
circulating levels of melatonin during the immedi-
ately subsequent night.
62 Likewise, tryptophan 32
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administration raised the circulating levels of both 
serotonin and melatonin in rats.
15,18 In sexually 
immature ringdoves, the administration of the 
amino acid increased nocturnal rest, which seem-
ingly correlated with the augmented circulating 
levels of melatonin caused by tryptophan treat-
ment.
169 Tryptophan signiﬁ  cantly increases the 
hippocampal, striatal, and hypothalamic serotonin 
contents,
10 and reduces the expression of c-fos in 
the suprachiasmatic nucleus.
170 C-fos levels are 
high in several cerebral regions during spontaneous 
waking or sleep deprivation and fall after a few 
hours of sleep.
171
In old ringdoves, the treatment with 300 mg of 
tryptophan per kg b.w. reduces nocturnal activity 
without affecting their diurnal activity, an effect 
accompanied by a general increase of serum sero-
tonin levels
16 This increase of serum serotonin 
indicates a higher availability of tryptophan which, 
after passing the blood–brain barrier, would be 
converted into serotonin.
10,15,18,31,62 The elevated 
serotonin in the pineal gland serves as a substrate 
for melatonin synthesis, and increases in the levels 
of this molecule would reduce nocturnal activity 
of old ringdoves,
16 improving their aging-impaired 
nocturnal rest.
7 Tryptophan administered at the 
same dose and time also provoked an improvement 
of the circadian rhythm of temperature in this 
species.
162
Regarding the innate immune response in old 
birds, treatment with tryptophan produced a sig-
niﬁ  cant diurnal and nocturnal augmentation in 
phagocytic parameters; the values reached during 
the night were signiﬁ  cantly higher that those mea-
sured during the day.
17 This is consistent with 
earlier findings demonstrating that giving the 
amino acid to mammals
15,62 or birds,
172 or melato-
nin itself to these species
14,154,165,173,174 has a general 
immuno-enhancing effect. Moreover, a reduced 
production of superoxide anion radicals in old 
ringdoves was observed after tryptophan treat-
ment.
17 This change was presumably due to the 
rise of the circulating serum levels of melatonin 
produced by the exogenous administration of its 
precursor.
16,17 This indicates that rising serum 
levels of melatonin are accompanied by a decline 
in the levels of superoxide anion radicals produced 
by heterophils, as reported previously. Also, tryp-
tophan signiﬁ  cantly limits the reduction in cell 
viability of heterophils exposed to hydrogen per-
oxide.
17 A similar effect was obtained when the 
cells are incubated with melatonin.
154 Furthermore, 
both the oral administration of the amino acid and 
the indole lowered cytokine levels in aged 
birds.
162
Concluding Remarks
A variety of studies on serotonin neurotransmission 
indicate that, as a consequence of aging, a reduc-
tion in the density of serotonin receptors and 
marked disturbance in the 5-hydroxindole acetic/
serotonin turnover and in the responses of the 
receptors/transporters to the hormonal regulation 
occur.
106,107 Many of these alterations result in a 
decreased serotonin binding. Furthermore, the 
production of melatonin suffers a dramatic decline 
with age.
13 These neurochemical changes may 
have etiologic implications in the altered behavior 
observed in old individuals and an underlying 
cause of several geriatric conditions, including the 
impaired sleep/wake cycle and immunosenes-
cence. The evidence obtained in the ringdove and 
other animal models suggests that the supplemen-
tal administration of tryptophan, e.g. the inclusion 
of tryptophan-enriched food in the diet, might help 
to remediate the reduction in serotonin and mela-
tonin that normally occurs as animals age, and be 
consequently beneﬁ  cial in the treatment of sleep 
problems and alterations in the innate immune 
response.
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